Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0P1UC
|
|||
| Former ID |
DNC013119
|
|||
| Drug Name |
2-(5-phenyl-furan-2-yl)-4,5-dihydro-1H-imidazole
|
|||
| Synonyms |
furaline; CHEMBL213439; SCHEMBL11783413
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H12N2O
|
|||
| Canonical SMILES |
C1CN=C(N1)C2=CC=C(O2)C3=CC=CC=C3
|
|||
| InChI |
1S/C13H12N2O/c1-2-4-10(5-3-1)11-6-7-12(16-11)13-14-8-9-15-13/h1-7H,8-9H2,(H,14,15)
|
|||
| InChIKey |
HNPLGLAMYJQFOS-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 3-[5-(4,5-dihydro-1H-imidazol-2-yl)-furan-2-yl]phenylamine (Amifuraline), a promising reversible and selective peripheral MAO-A inhibitor. J Med Chem. 2006 Sep 7;49(18):5578-86. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.